Form 4: J.H. Whitney Equity Partners VII, LLC Sells Aveanna Healthcare Holdings Shares

Sentiment:

SEC Form 4


J.H. Whitney Equity Partners VII, LLC reports the sale of Aveanna Healthcare Holdings, Inc. shares through a pre-arranged Rule 10b5-1 trading plan.

Summary

  • J.H. Whitney Equity Partners VII, LLC, a 10% owner of Aveanna Healthcare Holdings, Inc. (AVAH), filed a Form 4 detailing changes in beneficial ownership.
  • The transactions involved the sale of common stock on May 14 and 15, 2025, executed under a Rule 10b5-1 trading plan.
  • On May 14, 2025, 29,296 shares were sold at a weighted average price of $5.88, 14,637 shares were sold at a weighted average price of $5.88 and 1,355 shares were sold at a weighted average price of $5.88.
  • On May 15, 2025, 30,340 shares were sold at a weighted average price of $5.89, 15,158 shares were sold at a weighted average price of $5.89 and 1,403 shares were sold at a weighted average price of $5.89.
  • The sales were conducted by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC, with J.H. Whitney Equity Partners VII, LLC acting as the general partner or managing member.
  • Following the reported transactions, J.H. Whitney VII, L.P. beneficially owns 31,231,796 shares, PSA Healthcare Investment Holding LLC beneficially owns 15,603,740 shares and PSA Iliad Holdings LLC beneficially owns 1,444,546 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan. It doesn't inherently indicate positive or negative views on the company's future.

Negatives

  • The sale of shares by a significant shareholder could be perceived negatively by the market.

Risks

  • Continued sales under the Rule 10b5-1 trading plan could exert downward pressure on the stock price.
  • Changes in the ownership structure could potentially impact the company's strategic direction.

Future Outlook

The document does not provide specific forward-looking statements for Aveanna Healthcare Holdings, Inc., but indicates continued sales under the existing 10b5-1 trading plan.

Industry Context

The healthcare industry is subject to various regulations and market dynamics. Sales by major shareholders can sometimes reflect their portfolio strategies rather than specific concerns about the company's performance.

Comparison to Industry Standards

  • Comparing the trading activity to similar transactions by major shareholders in comparable healthcare companies would provide a benchmark.
  • Analyzing the volume of shares sold relative to the total outstanding shares and average daily trading volume can offer insights into the potential market impact.
  • Companies like Option Care Health (OPCH) and LHC Group (LHCG) could be considered for comparison, focusing on similar insider trading patterns and market reactions.

Stakeholder Impact

  • Shareholders may react to the reported sale of shares by a major shareholder.
  • Employees may be indirectly affected by any potential changes in the company's stock performance.

Key Dates

DateDescription
2024-12-13Date of adoption of Rule 10b5-1 trading plan by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, and PSA Iliad Holdings LLC.
2025-05-14Date of first reported transaction: Sale of Aveanna Healthcare Holdings, Inc. shares.
2025-05-15Date of second reported transaction: Sale of Aveanna Healthcare Holdings, Inc. shares.
2025-05-16Date of signature of the Form 4 filing.

Keywords

Aveanna Healthcare Holdings, AVAH, J.H. Whitney Equity Partners VII, Share Sale, Form 4, Rule 10b5-1, Beneficial Ownership, Stock Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.